Browsing Tag
gastrointestinal cancer
2 posts
Galmed Pharmaceuticals (Nasdaq: GLMD) reports Q3 loss but refocuses on oncology with new Aramchol data and once-daily formulation
Galmed Pharmaceuticals shifts focus to oncology after reporting Q3 loss; Aramchol Meglumine’s new formulation shows promise for 2026 Phase 2 trials.
FDA clears Mabwell’s next-gen ADC 7MW4911: What’s at stake in the global GI oncology race?
Mabwell secures FDA IND for CDH17-targeting ADC 7MW4911, marking a major step in GI cancer therapy. Find out how this could reshape advanced oncology care.